SIK1
SIK1 (salt inducible kinase 1, also known as msk or SNF1LK) is a serine/threonine protein kinase of the AMPK subfamily. It links cAMP, calcium and sodium signals to the control of transcription, metabolism, muscle differentiation and tumour suppression. Browse Assay Genie's current range of SIK1 research reagents below, or read on for the biology behind the target.
SIK1 phosphorylates a defined set of substrates, including HDAC4, HDAC5, PPME1, SREBF1 and CRTC1/TORC1. In response to cAMP signalling it phosphorylates and inhibits the CREB-specific coactivators CRTC2/TORC2 and CRTC3/TORC3, which restrains CREB activity. Through this route it regulates hepatic gluconeogenesis, and by phosphorylating and inhibiting SREBF1 it also regulates hepatic lipogenesis. Together with CRTC1/TORC1 it helps set light-induced entrainment of the circadian clock by attenuating PER1 induction.
In muscle, SIK1 phosphorylates and inhibits the class II histone deacetylases HDAC4 and HDAC5, which promotes expression of MEF2 target genes in myocytes. It is also required in cardiomyogenesis, where it regulates cell cycle exit of cardiomyoblasts through down-regulation of CDKN1C/p57Kip2. SIK1 acts as a tumour suppressor. It is required for p53/TP53 phosphorylation during anoikis, the apoptosis triggered by loss of cell adhesion, and it can suppress metastasis. It also belongs to a sodium-sensing network: when intracellular sodium rises, CaMK1 activates SIK1, which phosphorylates the PP2A subunit PPME1 and ultimately increases ATP1A1 activity.
The SIK1 gene encodes a protein with a ubiquitin-associated (UBA) domain. It belongs to the CAMK Ser/Thr protein kinase group, in the AMPK subfamily, and to the HGNC group of SIK family kinases alongside SIK2. A mutation in the gene is associated with early infantile epileptic encephalopathy 30. The protein is found in the cytoplasm and nucleus, and the earlier name SNF1-like kinase reflects its relationship to the yeast SNF1 kinase family.
SIK1 inhibits CRTC coactivators in response to cAMP, making it a point of control for CREB-dependent transcription.
SIK1 represses CRTC1 and CRTC2 and inhibits SREBF1, regulating gluconeogenesis and lipogenesis in the liver.
SIK1 acts as a tumour suppressor, is required for p53 phosphorylation after loss of adhesion, and can suppress metastasis.
SIK1 inhibits HDAC4 and HDAC5 to promote MEF2 target genes, and supports cardiomyoblast cell cycle exit.
SIK1 is a serine/threonine kinase that phosphorylates substrates such as HDAC4, HDAC5, PPME1, SREBF1 and CRTC coactivators. Through them it regulates CREB activity, gluconeogenesis, lipogenesis, muscle gene expression, circadian clock entrainment and p53-dependent anoikis.
SIK1 stands for salt inducible kinase 1. Aliases include msk and SNF1LK, and the previous name was SNF1-like kinase. UniProt lists the protein as serine/threonine-protein kinase SIK1. It is one of the SIK family kinases, which also include SIK2.
NCBI Gene reports that a mutation in SIK1 is associated with early infantile epileptic encephalopathy 30. UniProt also describes a tumour suppressor role in which SIK1 supports p53-dependent anoikis and can suppress metastasis. Mouse and rat both have a Sik1 ortholog; check the datasheet of any product for its validated reactivity.
Other members of the SIK kinase family with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P57059; product specifications from Assay Genie datasheets.